IUPHAR review: Targeted therapies of signaling pathways based on the gut microbiome in autism spectrum disorders: Mechanistic and therapeutic applications
Open Access
- 28 December 2024
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 211, 107559
Abstract
No abstract availableKeywords
This publication has 279 references indexed in Scilit:
- Etiology of Autism Spectrum Disorders and Autistic Traits Over TimeJAMA Psychiatry, 2020
- Changes in the Gut Microbiota of Children with Autism Spectrum DisorderAutism Research, 2020
- The joint effect of air pollution exposure and copy number variation on risk for autismAutism Research, 2017
- Maternal hirsutism and autism spectrum disorders in offspringAutism Research, 2017
- Paternal age and psychiatric disorders: A reviewAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2016
- The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomesClinical Pharmacology & Therapeutics, 2016
- Diagnosis and Treatment ofClostridium difficilein AdultsJAMA, 2015
- Costs of Autism Spectrum Disorders in the United Kingdom and the United StatesJAMA Pediatrics, 2014
- Molecular Characterisation of Gastrointestinal Microbiota of Children With Autism (With and Without Gastrointestinal Dysfunction) and Their Neurotypical SiblingsAutism Research, 2012
- Genes related to sex steroids, neural growth, and social–emotional behavior are associated with autistic traits, empathy, and Asperger syndromeAutism Research, 2009